159 related articles for article (PubMed ID: 34388137)
1. β6-Integrin Serves as a Potential Serum Marker for Diagnosis and Prognosis of Pancreatic Adenocarcinoma.
Lenggenhager D; Bengs S; Fritsch R; Hussung S; Busenhart P; Endhardt K; Töpfer A; The FO; Bütikofer S; Gubler C; Scharl M; Morell B
Clin Transl Gastroenterol; 2021 Aug; 12(8):e00395. PubMed ID: 34388137
[TBL] [Abstract][Full Text] [Related]
2. β
Bengs S; Becker E; Busenhart P; Spalinger MR; Raselli T; Kasper S; Lang S; Atrott K; Mamie C; Vavricka SR; von Boehmer L; Knuth A; Tuomisto A; Mäkinen MJ; Hruz P; Turina M; Rickenbacher A; Petrowsky H; Weber A; Frei P; Halama M; Jenkins G; Sheppard D; Croner RS; Christoph J; Britzen-Laurent N; Naschberger E; Schellerer V; Stürzl M; Fried M; Rogler G; Scharl M
Int J Cancer; 2019 Aug; 145(3):678-685. PubMed ID: 30653264
[TBL] [Abstract][Full Text] [Related]
3. Integrin-β6 Serves as a Potential Prognostic Serum Biomarker for Gastric Cancer.
Li Z; Sun Y; Xu J; Yang H; Liu X; Tian Y; Cao S; Zhou Y
Front Oncol; 2021; 11():770997. PubMed ID: 34796117
[TBL] [Abstract][Full Text] [Related]
4. Glycoprotein biomarkers for the detection of pancreatic ductal adenocarcinoma.
Llop E; E Guerrero P; Duran A; Barrabés S; Massaguer A; José Ferri M; Albiol-Quer M; de Llorens R; Peracaula R
World J Gastroenterol; 2018 Jun; 24(24):2537-2554. PubMed ID: 29962812
[TBL] [Abstract][Full Text] [Related]
5. Serum tumor antigen REG4 as a diagnostic biomarker in pancreatic ductal adenocarcinoma.
Takayama R; Nakagawa H; Sawaki A; Mizuno N; Kawai H; Tajika M; Yatabe Y; Matsuo K; Uehara R; Ono K; Nakamura Y; Yamao K
J Gastroenterol; 2010; 45(1):52-9. PubMed ID: 19789838
[TBL] [Abstract][Full Text] [Related]
6. High expression of integrin β6 in association with the Rho-Rac pathway identifies a poor prognostic subgroup within HER2 amplified breast cancers.
Desai K; Nair MG; Prabhu JS; Vinod A; Korlimarla A; Rajarajan S; Aiyappa R; Kaluve RS; Alexander A; Hari PS; Mukherjee G; Kumar RV; Manjunath S; Correa M; Srinath BS; Patil S; Prasad MS; Gopinath KS; Rao RN; Violette SM; Weinreb PH; Sridhar TS
Cancer Med; 2016 Aug; 5(8):2000-11. PubMed ID: 27184932
[TBL] [Abstract][Full Text] [Related]
7. Expression and diagnostic value of HE4 in pancreatic adenocarcinoma.
Huang T; Jiang SW; Qin L; Senkowski C; Lyle C; Terry K; Brower S; Chen H; Glasgow W; Wei Y; Li J
Int J Mol Sci; 2015 Jan; 16(2):2956-70. PubMed ID: 25642754
[TBL] [Abstract][Full Text] [Related]
8. Serum CA 19-9 and CEA levels as a prognostic factor in pancreatic adenocarcinoma.
Lee KJ; Yi SW; Chung MJ; Park SW; Song SY; Chung JB; Park JY
Yonsei Med J; 2013 May; 54(3):643-9. PubMed ID: 23549809
[TBL] [Abstract][Full Text] [Related]
9. Elevated serum CA72-4 levels predict poor prognosis in pancreatic adenocarcinoma after intensity-modulated radiation therapy.
Liu P; Zhu Y; Liu L
Oncotarget; 2015 Apr; 6(11):9592-9. PubMed ID: 25860937
[TBL] [Abstract][Full Text] [Related]
10. Prognostic analysis of patients with pancreatic head adenocarcinoma less than 2 cm undergoing resection.
Chiang KC; Yeh CN; Lee WC; Jan YY; Hwang TL
World J Gastroenterol; 2009 Sep; 15(34):4305-10. PubMed ID: 19750574
[TBL] [Abstract][Full Text] [Related]
11. Serum fibrinogen as a diagnostic and prognostic biomarker for pancreatic ductal adenocarcinoma.
Chung KH; Lee JC; Lee J; Cho IK; Kim J; Jang W; Yoo BC; Hwang JH
Pancreatology; 2020 Oct; 20(7):1465-1471. PubMed ID: 32873483
[TBL] [Abstract][Full Text] [Related]
12. Is a preoperative assessment of the early recurrence of pancreatic cancer possible after complete surgical resection?
La Torre M; Nigri G; Lo Conte A; Mazzuca F; Tierno SM; Salaj A; Marchetti P; Ziparo V; Ramacciato G
Gut Liver; 2014 Jan; 8(1):102-8. PubMed ID: 24516708
[TBL] [Abstract][Full Text] [Related]
13. Integrin β6 acts as an unfavorable prognostic indicator and promotes cellular malignant behaviors via ERK-ETS1 pathway in pancreatic ductal adenocarcinoma (PDAC).
Li Z; Lin P; Gao C; Peng C; Liu S; Gao H; Wang B; Wang J; Niu J; Niu W
Tumour Biol; 2016 Apr; 37(4):5117-31. PubMed ID: 26547582
[TBL] [Abstract][Full Text] [Related]
14.
Soejima Y; Takeuchi M; Miyamoto N; Sawabe M; Fukusato T
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34208313
[TBL] [Abstract][Full Text] [Related]
15. A prospective study of serum tumour markers carcinoembryonic antigen, carbohydrate antigens 50 and 242, tissue polypeptide antigen and tissue polypeptide specific antigen in the diagnosis of pancreatic cancer with special reference to multivariate diagnostic score.
Pasanen PA; Eskelinen M; Partanen K; Pikkarainen P; Penttilä I; Alhava E
Br J Cancer; 1994 Mar; 69(3):562-5. PubMed ID: 8123488
[TBL] [Abstract][Full Text] [Related]
16. Inflammasome and cytokine expression profiling in experimental periodontitis in the integrin β6 null mouse.
Bi J; Dai J; Koivisto L; Larjava M; Bi L; Häkkinen L; Larjava H
Cytokine; 2019 Feb; 114():135-142. PubMed ID: 30467097
[TBL] [Abstract][Full Text] [Related]
17. Novel Diagnostic and Predictive Biomarkers in Pancreatic Adenocarcinoma.
Chang JC; Kundranda M
Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28335509
[TBL] [Abstract][Full Text] [Related]
18. Exploring the role of ITGB6: fibrosis, cancer, and other diseases.
Zhang Z; Wang Z; Liu T; Tang J; Liu Y; Gou T; Chen K; Wang L; Zhang J; Yang Y; Zhang H
Apoptosis; 2024 Jun; 29(5-6):570-585. PubMed ID: 38127283
[TBL] [Abstract][Full Text] [Related]
19. Serum microRNA expression profile as a biomarker in the diagnosis and prognosis of pancreatic cancer.
Liu R; Chen X; Du Y; Yao W; Shen L; Wang C; Hu Z; Zhuang R; Ning G; Zhang C; Yuan Y; Li Z; Zen K; Ba Y; Zhang CY
Clin Chem; 2012 Mar; 58(3):610-8. PubMed ID: 22194634
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance and prognostic value of CA72-4 compared with CEA and CA19-9 in patients with gastric cancer.
Ychou M; Duffour J; Kramar A; Gourgou S; Grenier J
Dis Markers; 2000; 16(3-4):105-10. PubMed ID: 11381189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
